| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Microbiology Group, School of Pharmacy, 29–39 Brunswick Square, London WC1N 1AX, UK
2 Bayer Healthcare AG, Pharma Research Center, D-42096 Wuppertal, Germany
3 Mitsui Norin Co. Ltd, 1-2-9 Nishi-Shinbashi, Minato-Ku, Tokyo 105-8427, Japan
Correspondence
Peter W. Taylor
peter.taylor{at}pharmacy.ac.uk
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). The capacity of S. aureus to acquire genes that confer antibiotic resistance, combined with the mutation of host genes, has facilitated the evolution of a multi-resistant pathogen for which treatment options can be severely limited. Until recently, the glycopeptide antibiotics vancomycin and teicoplanin were universally active against MRSA, but the isolation of vancomycin-intermediate-resistant S. aureus (VISA) (Hiramatsu et al., 1997) and fully vancomycin-resistant S. aureus (VRSA) isolates (Centers for Disease Control, 2002) serves to illustrate the need to maintain the search for new antimicrobial agents and to find new treatment strategies (Appelbaum, 2006). Although the utility of many, if not all, antibiotics is eroded over time due to the emergence of resistance, an opportunity exists to restore their efficacy by co-administration of compounds that compromise determinants of antibiotic resistance (Taylor et al., 2002). For example, the combination of β-lactam antibiotics and β-lactamase inhibitors, such as amoxicillin-clavulanate formulations, have for two decades proven to be remarkably effective in controlling a wide range of bacterial infections (Miller et al., 2001).
The galloylated catechins (–)-epicatechin gallate (ECg) and (–)-epigallocatechin gallate (EGCg) are structurally related constituents (Fig. 1a) of green tea (Camellia sinensis) that share a capacity to reduce PBP2a-mediated oxacillin resistance in S. aureus, rendering genotypically resistant strains susceptible to β-lactam antibiotic action (Shiota et al., 1999; Zhao et al., 2001; Stapleton et al., 2004). Non-galloylated catechins, such as (–)-epicatechin (EC), are unable to modulate β-lactam resistance but act synergistically with ECg, lowering the concentration of ECg required to eliminate β-lactam resistance in S. aureus (Stapleton et al., 2006). The process by which galloylated catechins reduce β-lactam resistance has not been elucidated. A 2 % (w/v) green tea extract has been reported to reduce the expression by a MRSA isolate of PBP1, PBP2a, and to some extent PBP3 (Yam et al., 1998). However, the ability to detect the presence of PBP2a in S. aureus isolates grown in the presence of EGCg suggests that a reduction in expression of PBP2a may not account for the observed changes in β-lactam susceptibility (Zhao et al., 2001). Furthermore, the capacity of EGCg to reduce oxacillin resistance in a S. aureus isolate has been reported to be compromised by the addition of peptidoglycan to the growth medium (Zhao et al., 2001); these authors proposed that EGCg blocks PBP substrate access by binding to peptidoglycan. If steric hindrance by peptidoglycan were solely responsible, it would seem likely that the activity of all PBPs would be similarly affected and the MICs of the compounds would be low. In fact, the MICs for galloylated catechins, in the absence of a β-lactam antibiotic, are high (64–256 µg ml–1) and are similar to those for non-galloylated catechins (256–512 µg ml–1) (Stapleton et al., 2004). In addition, several studies have highlighted the interaction between catechins and lipid bilayers (Hashimoto et al., 1999; Kajiya et al., 2001, 2002; Caturla et al., 2003). Indeed, the capacity of catechins to reduce β-lactam resistance closely correlates with the degree of penetration of the molecule into membrane bilayers (Stapleton et al., 2006).
|
), reduce slime production and inhibit the formation of biofilms in staphylococcal cell cultures (Blanco et al., 2005). In order to gain insight into the molecular basis of these phenomena, we have investigated the effect of ECg on cell-wall and cell-surface properties of S. aureus strains. |
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
).
Preparation of purified cell-wall extracts.
Peptidoglycan was extracted and purified according to the procedures described by Stranden et al. (1997), with the exception that strains were grown in MH broth.
HPLC analysis of peptidoglycan.
Preparation and analysis were performed using the procedures of Stranden et al. (1997) and Roos et al. (1998). Amino acid composition was determined by Alta Bioscience.
Measurement of phosphorus content of purified cell walls.
Total phosphorus was determined by the procedure of Fiske & SubbaRow as described by Leloir & Cardini (1957).
Effect of exogenous peptidoglycan on catechin activity.
The capacity of ECg and EGCg to reduce oxacillin resistance in the presence of exogenous peptidoglycan was measured using the method of Zhao et al. (2001).
Effect of ECg on adherence of MRSA to glass.
Cultures were grown in glass conical flasks in the presence or absence of 12.5 µg ECg ml–1 without shaking at 37 °C. Adherence was determined by visual inspection of the flasks.
Membrane extraction and PBP profiles.
Cytoplasmic membrane fractions were prepared from late exponential phase cultures (OD600 0.8–0.9). Cells were recovered by centrifugation (13 000 g, 10 min), washed once in phosphate-buffered saline and suspended in 1 ml ice-cold water. The cells were disrupted with glass beads (0.1 mm) using a FastPrep cell disruption system (40 s, power setting 6) and the cell-wall debris removed by centrifugation (13 000 g, 10 min). To isolate the cytoplasmic membrane fraction, the supernatant was subjected to ultracentrifugation (Beckman Optima MAX ultracentrifuge; 130 000 g, 1 h, 4 °C), and the pellet suspended in 10 mM Tris/HCl, pH 7 containing 2 % (v/v) Triton X-100. The protein content of the samples was quantified using a NanoOrange Protein Quantification kit (Invitrogen) in accordance with the manufacturer's instructions.
PBPs in the membrane preparations were selectively labelled by pre-incubation of the samples (10 µg protein) with 25 µM Bocillin FL (Invitrogen) for 10 min at 37 °C. The proteins in the sample were separated by SDS-PAGE (SDS 10 %, w/v) and the PBPs detected by fluorography (Bio-Rad Molecular Imager FX; excitation 488 nm, emission 530 nm). To detect PBP2a by fluorography the sequential binding assay described by Hartman & Tomasz (1984) was used: meticillin (600 µg ml–1), which has low affinity for PBP2a, was pre-incubated with the sample for 10 min prior to incubation with bocillin. To evaluate its PBP-inhibiting potential, 25 µg ECg ml–1 was pre-incubated with the sample for 10 min prior to bocillin labelling.
PBP2a detection.
Membrane protein preparations (10 µg) were separated by SDS-PAGE (SDS 10 %, w/v) and transferred onto an Immobilon PVDF membrane (Millipore) by electroblotting (Trans Blot Cell, Bio-Rad). PBP2a was specifically labelled with a mouse anti-PBP2a antibody (Oxoid PBP2a latex agglutination kit; 1 : 10 000 dilution), and detected with a second anti-mouse IgG peroxidase-conjugated antibody (Sigma-Aldrich; 1 : 8000 dilution) using 3,3',5,5'-tetramethylbenzidine (Sigma-Aldrich) as substrate.
Lysostaphin MIC.
The lowest concentration of lysostaphin to inhibit the growth of S. aureus was determined in a 96-well microtitre tray (100 µl MH broth per well) with an inoculum of approx. 104 c.f.u. The trays were incubated at 35 °C for 24 h.
Lysostaphin and mutanolysin hydrolysis assays.
Purified peptidoglycan was suspended (OD600 0.5) in 50 mM Tris/HCl (pH 7.5) containing 145 mM NaCl (lysostaphin assay) or 25 mM phosphate buffer, pH 5.5 (mutanolysin assay). Peptidoglycan hydrolysis was monitored by following the decrease in OD600 of the samples incubated at 37 °C with either 4 U lysostaphin (Sigma-Aldrich) or 12 U mutanolysin. To remove teichoic acid from the samples, peptidoglycan was suspended in 10 % (v/v) TCA for 24 h at 4 °C. Peptidoglycan was recovered by centrifugation and washed several times with water before the hydrolysis assays were performed.
Bacteriolytic assay of autolysins in culture medium supernatants.
The bacteriolytic assay was performed using a modification of the technique described by Fournier & Hooper (2000); 16 h cultures (37 °C, no shaking), grown in the presence and absence of ECg, were recovered by centrifugation (10 000 g, 10 min), and the supernatants filtered (0.2 µm). Supernatants were mixed with 0.1 M phosphate buffer (pH 7.0) containing heat-killed S. aureus BB568 cells (10 mg dry weight cells ml–1) and the cell suspensions incubated at 37 °C with shaking (200 r.p.m.). Bacteriolytic enzyme activity was assessed by measurement of OD600 of the cell suspensions at hourly intervals.
Triton X-100-induced autolytic assay.
This assay was performed as described by de Jonge et al. (1991). Briefly, S. aureus isolates were grown to an OD600 0.3 in the presence and absence of 25 µg ECg ml–1. The cultures were chilled on ice and cells recovered by centrifugation (10 000 g, 4 °C, 10 min). Cell pellets were washed once with ice-cold water and cells suspended (OD600 1.0) in assay buffer (50 mM glycine, 0.01 %, v/v, Triton X-100, pH 8.0). Autolysis was monitored at 30 min intervals by measuring the OD600 of the cultures incubated at 37 °C with shaking (200 r.p.m.).
Preparation of autolysin extracts and bacteriolytic profiles.
Cell-wall autolysin extracts were prepared from cultures grown to OD600 0.7–0.8. Cells were harvested by centrifugation, washed once with phosphate-buffered saline and autolysins extracted with 4 % (w/v) SDS for 30 min at room temperature. Cells were removed from the extracts by centrifugation. To extract autolysins from the culture medium, supernatants from 16 h cultures (37 °C, no shaking), grown in the presence or absence of 25 µg ECg ml–1, were recovered by centrifugation (10 000 g, 10 min) and concentrated 30-fold using a Centriplus YM-10 filter (Millipore; <10 kDa).
Proteins (10 µg per sample) were separated by 10 % (w/v) SDS-PAGE on gels containing heat-killed S. aureus BB568 cells (0.1 %, w/v). SDS was removed by soaking the gel in water and the lytic enzyme profile developed by incubating gels in 0.1 M phosphate buffer (pH 7.0) at 37 °C for 16 h. The profile was visualized by staining the gel with 1 % (w/v) methylene blue in 0.01 % (w/v) KOH, followed by destaining in water.
Lipoteichoic acid (LTA) release.
LTA release was determined as described by Suzuki et al. (1997).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). The non-galloylated catechin EC had no affect on the inhibitory action of oxacillin against BB568. However, 12.5 µg ECg ml–1 and 12.5 µg EGCg ml–1 reduced the oxacillin MIC to 4 and 16 µg ml–1 respectively. Exogenous peptidoglycan had no effect on the capacity of the non-galloylated compounds to reduce the oxacillin MICs against BB568 (Fig. 1) and against EMRSA-15 and EMRSA-16 (data not shown). As previously reported (Stapleton et al., 2004), ECg reduced the oxacillin MICs of 40 MRSA clinical isolates to a comparable extent. As previously reported (Stapleton et al., 2004), ECg reduced the oxacillin MICs of 40 MRSA clinical isolates to a comparable extent.
ECg promotes cell aggregation and reduces adherence to glass
ECg (Fig. 2c), but not EC (Fig. 2b), promoted cell aggregate formation in EMRSA-15, indicating that the galloyl group, found in ECg but not EC, may play a role in determining this activity. Gallic acid did not promote cell aggregation (data not shown), indicating that the gallate moiety alone did not mediate the effect. Cells grown in the presence of ECg failed to adhere to the surface of the glass flask and formed cell aggregates within the growth medium (Fig. 2d), suggesting that ECg alters the surface properties of the cell.
|
). The rates of Triton X-100-induced autolysis of three MRSA isolates (S. aureus BB568, EMRSA-15, and EMRSA-16) and one meticillin-susceptible S. aureus (MSSA) isolate (S. aureus BB551) were assessed following growth in the presence and absence of 25 µg ECg ml–1. Growth in the presence of ECg elicited greater than 40 % reduction in the rate of Triton X-100-induced autolysis in all strains (Fig. 3); after 2.5 h, a 78 % reduction in the original OD600 was observed for the ECg-grown cells at this time interval. EC had no effect on the rate of Triton X-100-induced autolysis (data not shown). Cell walls from bacteria grown in the presence and absence of ECg were hydrolysed at the same rate by an autolysin extract obtained from the growth medium of bacteria grown in the absence of ECg, providing evidence that Triton X-100-induced autolysis was not due to altered substrate.
|
). The profiles of cell-wall-associated bacteriolytic enzymes were broadly similar for bacteria grown in the absence of ECg and over a range of 25–100 µg ECg ml–1, although walls from ECg-grown cells elicited additional bands and concentration-dependent increases in the degree of cell lysis associated with the enzyme profiles (Fig. 4a). These observations suggested either that autolysin production was increased in ECg-grown cells or that there was a greater degree of autolysin retention within the cell wall in the presence of ECg. Therefore, culture medium supernatants from cells grown in the presence and absence of ECg were recovered by centrifugation, concentrated by filtration, and the autolytic profile determined by zymography: 25 µg ECg ml–1 reduced and 
50 µg ECg ml–1 suppressed the release of lytic enzymes into the growth medium (Fig. 4b), a result confirmed by direct measurement of the bacteriolytic activity of autolysins within the culture medium supernatants (Fig. 4c).
|
Teichoic acid reduces lysostaphin activity in ECg-grown cells
To further investigate the nature of the ECg-mediated reduced susceptibility to lysostaphin, peptidoglycan with covalently bound wall teichoic acid (WTA; a polymer consisting of ribitol residues linked by phosphodiester linkages) was extracted and purified from S. aureus BB568 cells grown in the presence or absence of 12.5 µg ECg ml–1. Consistent with the whole-cell studies, peptidoglycan with covalently bound WTA extracted from ECg-grown cells had reduced susceptibility to lysostaphin hydrolysis. Removal of WTA from the peptidoglycan by acid treatment restored the capacity of lysostaphin to hydrolyse peptidoglycan from ECg-grown cells. Therefore, ECg-induced alterations to teichoic acid, either conformational or structural, are likely to account for the reduced lysostaphin susceptibility. Pre-incubation of peptidoglycan and covalently bound WTA (extracted from non-ECg-grown cells) with 12.5 µg ECg ml–1 had no effect on the capacity of lysostaphin to hydrolyse peptidoglycan, indicating it is unlikely that a conformational change induced by direct binding of ECg to WTA or peptidoglycan could account for the observed inhibition. Measurement of the phosphorus content of WTA, an indication of the relative quantities of teichoic acid in the samples, revealed no differences between ECg-grown and control cells: the phosphorus content was 750 and 718 mmol per mg cell wall for non-ECg-grown and ECg-grown BB568 cells respectively.
Increased mutanolysin hydrolysis of peptidoglycan from ECg-grown cells
In order to determine if reduced susceptibility of peptidoglycan to hydrolytic activity was restricted to lysostaphin, the activity of a second peptidoglycan hydrolase, mutanolysin, was investigated. Mutanolysin is an enzyme that cleaves the glycosidic bonds between disaccharide residues in peptidoglycan and thus acts at a site distinct from lysostaphin. In contrast to lysostaphin, a small increase in the rate of mutanolysin hydrolysis of peptidoglycan extracted from ECg-grown cells was observed (Fig. 5a) which was enhanced in the absence of WTA (Fig. 5b). Furthermore, the difference in the rate of hydrolysis between cells grown in the absence and presence of ECg was not dependent on the degree of O-acetylation of the peptidoglycan; removal of O-acetyl groups through exposure to strongly alkaline conditions had no effect on the hydrolytic capacity of mutanolysin (data not shown).
|
).
|
). In BB568 and EMRSA-16, the degree of cross-linking was reduced by 5–10 % (indicated by a reduction in the quantities of high molecular mass muropeptides detected and reflected in a decrease in area under the curve for fragments eluting between 120 and 180 min) when grown in the presence of 12.5 µg ECg ml–1, suggesting that ECg interfered with PBP production and/or PBP activity.
|
). Growth of BB568 in the presence of ECg led to a reduction in the quantities of PBP1 (reduced by 40 %) and PBP3 (reduced by 33 %) detected (Fig. 8b). In order to distinguish between reduced PBP expression and PBP inhibition, PBP preparations were pre-incubated with ECg prior to bocillin labelling. This procedure revealed that PBP3 labelling was unaffected by the presence of ECg and, consequently, the reduction in bocillin binding observed was most likely due to reduced PBP3 production (Fig. 8b). In contrast, pre-incubation with ECg resulted in a reduction of bocillin binding to PBP1 of 36–48 % (Fig. 8b). EC had no effect on bocillin-labelling of PBPs (data not shown).
|
). With this technique, no differences in the quantity of PBP2a were detected when BB568 cells were grown in the presence of ECg (Fig. 8a). No differences in bocillin binding to PBP2 and PBP2a were found following pre-incubation with ECg. Furthermore, PBP2a was detected using anti-PBP2a immunoblotting; the intensity of the bands appeared very similar (except at 6.25 µg ECg ml–1, where a slight increase in intensity was observed) in preparations from BB568 cells grown in medium containing a wide range of ECg concentrations (Fig. 8c). |
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Shirai et al., 1998; Stapleton & Taylor, 2002). Our earlier studies established that the gallate moiety, found in ECg but not EC, is an essential requirement for modulation of β-lactam resistance in S. aureus by catechins (Stapleton et al., 2004). The conclusions of the present study, that cell aggregation, Triton X-100-induced autolysis, lysostaphin susceptibility and LTA release were promoted by ECg but not EC, are consistent with this observation.
In contrast to a previous report (Zhao et al., 2001), we were unable to demonstrate that the presence of exogenous peptidoglycan compromised the capacity of ECg or EGCg to reduce PBP2a-mediated β-lactam resistance and we believe it unlikely that ECg and EGCg exert their resistance-modifying effects by binding directly to peptidoglycan. We were able to demonstrate reduced binding of penicillin to PBP1 and PBP3 in the presence of ECg, an observation that is consistent with the study of Hamilton-Miller & Shah (1999). However, in agreement with Zhao et al. (2001), we were unable to demonstrate a reduced expression of PBP2a, although we cannot rule out that direct binding of ECg to PBP2a may account for the observed reductions in β-lactam resistance.
Growth of MRSA in ECg-containing medium resulted in a small reduction in the degree of peptidoglycan cross-linking, presumably reflecting the capacity of ECg to reduce the activities of PBP2 and PBP4; in contrast to other PBPs, inhibition of the activity of these two proteins leads to a reduction in peptidoglycan cross-linking observed by HPLC muropeptide profiling. As growth in the presence of ECg neither reduced the binding of bocillin to PBP2 and PBP4 nor reduced the expression of these proteins, ECg is likely to affect their activity indirectly. The activities of PBP2, PBP4 and PBP2a are linked in an interdependent fashion (
ski & Tomasz, 2005) and, as ECg may interfere with the interaction of PBP2 (and/or PBP4) and PBP2a, interruption of functional cooperation may account for ECg-mediated reductions in oxacillin resistance. Reduced PBP cooperation could be due to reduced mobility of proteins in the cytoplasmic membrane resulting from insertion of ECg into the bilayer, or to inhibition of protein–protein interactions following binding of ECg to PBPs.
PBP3 is not essential for staphylococcal growth and its inactivation appears to have few consequences other than a small decrease in autolysis (Pinho et al., 2000). On the other hand, PBP1 is essential for the viability of MSSA (Pinho et al., 2000). It remains to be determined if this is also the case for MRSA, but presumably PBP2a could substitute for the transpeptidase activity of PBP1 in MRSA if the activity of this protein was severely compromised by ECg. However, the muropeptide profiles obtained in this study provided no evidence for PBP2a enzymic activity in ECg-grown cells: PBP2a activity in the presence of low concentrations of meticillin results in an abnormal muropeptide profile (de Jonge & Tomasz, 1993) and such changes were not found in this study.
Like Cibracon blue F3GA (Shirai et al., 1998), ECg inhibits cell separation. Cibacron blue F3GA promotes cell aggregation by directly inhibiting endo-β-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase; these bacteriolytic enzymes are involved in cell separation (Sugai et al., 1990, 1995). Importantly, studies with Cibracon blue have shown that secretion of the autolysins into the growth medium is a prerequisite for cell separation (Sugai et al., 1995). We found that ECg-grown cells also retained autolysins within the cell wall, and autolysin release into the growth medium was markedly reduced; these observations are consistent with the report by Hamilton-Miller & Shah (1999) that tea polyphenols reduce cell separation and result in formation of pseudomulticellular forms. However, bacteriolytic enzyme inhibition by Cibacron blue F3GA does not account for its capacity to reduce oxacillin resistance in S. aureus (Shirai et al., 1998) and by analogy this may also be the case for ECg.
Although autolysins accumulated within the cell wall of ECg-grown cells, the degree of Triton X-100-induced autolysis was markedly reduced. This apparent contradiction indicated that cell-wall-associated autolysin activity was compromised, a contention supported by the observation that lysostaphin had a reduced capacity to hydrolyse whole cells and peptidoglycan extracted from ECg-grown bacteria. This reduced lysostaphin activity was not due to alterations in the formation of peptidoglycan pentaglycine cross-bridges (the substrate for lysostaphin) but was associated with the acid-labile component, teichoic acid. Interestingly, teichoic acid-mediated lysostaphin resistance is associated with the VISA isolates VM, JH-9 and JH-14; these also exhibit greatly reduced β-lactam resistance (Sieradzki et al., 1999; Sieradzki & Tomasz, 1996, 2003). In addition, these VISA isolates have, in a similar fashion to ECg-grown cells, an increased autolysin cell-wall content, reduced Triton X-100-induced autolysis and the tendency to grow as aggregates (Sieradzki & Tomasz, 2003). In this study we have established that ECg does not directly interfere with lysostaphin activity by binding to peptidoglycan, teichoic acid or lysostaphin. Unlike the ‘JH-series’ VISA isolates, which have increased quantities of teichoic acid associated with the cell wall (Sieradzki & Tomasz, 2003), no difference in teichoic acid content was observed in ECg-grown cells compared to cells grown in the absence of ECg, making it probable that changes to the structure of teichoic acid that confer reduced lysostaphin resistance occur during growth in ECg-containing medium. Variations in the D-alanine content of teichoic acid are known to significantly alter the properties of the cell wall; increases in the D-alanine content of WTA increase lysostaphin susceptibility but have only a minor affect on β-lactam susceptibility (Peschel et al., 2000). We are currently attempting to determine if ECg-grown cells possess modified teichoic acid.
Peptidoglycan extracted from ECg-grown cells had an increased susceptibility to mutanolysin and was similar in this regard to the VISA isolate VM described by Sieradzki et al. (1999). The increase in mutanolysin susceptibility of ECg-grown cells was not due to changes in O-acetylation, a modification known to affect lysozyme and mutanolysin activity (Bera et al., 2005), but probably resulted from reduced peptidoglycan cross-linking, as proposed for the VISA isolates (Sieradzki et al., 1999).
Although the VISA phenotype is heterogeneous, reduced Triton X-100-induced autolysis, lysostaphin susceptibility and increased cell-wall thickness are frequently associated with reduced vancomycin susceptibility (Boyle-Vavra et al., 2001; Koehl et al., 2004; Wootton et al., 2005). ECg-grown cells share these characteristics but we found no evidence that they possess decreased vancomycin susceptibility (unpublished data). This may be related to the expression of PBP4 in ECg-grown cells; reduced PBP4 expression is known to contribute to the VISA phenotype (Sieradzki et al., 1999; Finan et al., 2001).
In addition to its effects on WTA, ECg also stimulated LTA release. LTA is normally released from the cytoplasmic membrane in small quantities during staphylococcal cell growth, but its release can be stimulated by incubation with β-lactam antibiotics at concentrations equal to or above the MIC (Raynor et al., 1979; van Langevelde et al., 1998). ECg has only minimal impact on the degree of peptidoglycan cross-linking and it is unlikely that ECg-related modulation of cell-wall structure can account for the high levels of LTA that are released following growth in the presence of this catechin. Triton X-100 has, like ECg, the capacity to reduce β-lactam resistance in S. aureus and to promote LTA displacement and release from the cytoplasmic membrane (Raychaudhuri & Chatterjee, 1985; Suzuki et al., 1997). Indeed, it has been proposed that Triton X-100 sensitizes MRSA to oxacillin by virtue of its capacity to engender the release of LTA (Ohta et al., 2000). Like Triton X-100, non-galloylated and galloylated catechins interact with lipid bilayers (Hashimoto et al., 1999; Caturla et al., 2003; Kajiya et al., 2001, 2002) and their degree of penetration into lipid bilayers mirrors their capacity to modulate oxacillin resistance. Thus, active galloylated catechins such as ECg penetrate deep into the phospholipid palisade whereas non-active non-galloylated catechins such as EC occupy a more superficial location (Caturla et al., 2003; Stapleton et al., 2006). EC was unable to stimulate LTA release and its degree of penetration into the bilayer is insufficient to displace LTA. Conversely, the deeper location afforded to ECg facilitated LTA displacement.
In this study, we have examined the consequences of growth in ECg-containing medium on the staphylococcal cell in relation to the capacity of this naturally occurring polyphenol to sensitize MRSA isolates to β-lactam antibiotics. We have been able to discount ECg-mediated reduction in PBP2a expression and ECg binding to peptidoglycan as factors affecting ECg action, although we cannot yet exclude the possibility that modulation of antibiotic resistance may be related to inhibition of the enzymic activity of PBP2a. ECg inserts into the cytoplasmic membrane, releases LTA and is likely to effect changes to the structure of WTA; these events affect the surface properties of the cell and probably account for the retention of autolysins within the cell wall, altered autolysin activity and reduced adherence. We are currently investigating the interrelationships between these factors in the context of modulation of β-lactam susceptibility.
|
ACKNOWLEDGEMENTS |
|---|
Edited by: J. H. Cove
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Bera, A., Herbert, S., Jakob, A., Vollmer, W. & Götz, F. (2005). Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55, 778–787.[CrossRef][Medline]
Blanco, A. R., Sudano-Roccaro, A., Spoto, G. C., Nostro, A. & Rusciano, D. (2005). Epigallocatechin gallate inhibits biofilm formation by ocular staphylococcal isolates. Antimicrob Agents Chemother 49, 4339–4343.
Boyle-Vavra, S., Carey, R. B. & Daum, R. S. (2001). Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother 48, 617–625.
Caturla, N., Vera-Samper, E., Villalaín, J., Mateo, C. R. & Micol, V. (2003). The relationship between the antioxidant and the antibacterial properties of galloylated catechins and the structure of phospholipid model membranes. Free Radic Biol Med 34, 648–662.[CrossRef][Medline]
Centers for Disease Control (2002). Staphylococcus aureus resistant to vancomycin – United States, 2002. MMWR Morbid Mortal Wkly Rep 51, 565–567.[Medline]
Crisóstomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C. & de Lencastre, H. (2001). The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A 98, 9865–9870.
de Jonge, B. L. M. & Tomasz, A. (1993). Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis. Antimicrob Agents Chemother 37, 342–346.
de Jonge, B. L. M., de Lancastre, H. & Tomasz, T. (1991). Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J Bacteriol 173, 1105–1110.
Finan, J. E., Archer, G. L., Pucci, M. J. & Climo, M. W. (2001). Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45, 3070–3075.
Fournier, B. & Hooper, D. C. (2000). A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J Bacteriol 182, 3955–3964.
Hamilton-Miller, J. M. T. & Shah, S. (1999). Disorganization of cell division of methicillin-resistant Staphylococcus aureus by a component of tea (Camellia sinensis): a study by electron microscopy. FEMS Microbiol Lett 176, 463–469.[CrossRef][Medline]
Hartman, B. J. & Tomasz, A. (1984). Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol 158, 513–516.
Hashimoto, T., Kumazawa, S., Nanjo, F., Hara, Y. & Nakayama, T. (1999). Interaction of tea catechins with lipid bilayers investigated with liposome systems. Biosci Biotechnol Biochem 63, 2252–2255.[CrossRef][Medline]
Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. & Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135–136.
Kajiya, K., Kumazawa, S. & Nakayama, T. (2001). Steric effects on interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 65, 2638–2643.[CrossRef][Medline]
Kajiya, K., Kumazawa, S. & Nakayama, T. (2002). Effects of external factors on the interaction of tea catechins with lipid bilayers. Biosci Biotechnol Biochem 66, 2330–2335.[CrossRef][Medline]
Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Ehlert, K., Labischinski, H. & Wilkinson, B. (2004). Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 48, 3749–3757.
Leloir, L. F. & Cardini, C. E. (1957). Characterization of phosphorus compound by acid lability. Methods Enzymol 3, 840–850.
ski, T. A. & Tomasz, A. (2005). Role of penicillin-binding protein 2 (PBP2) in the antibiotic susceptibility and cell wall cross-linking of Staphylococcus aureus: evidence for the cooperative functioning of PBP2, PBP4 and PBP2A. J Bacteriol 187, 1815–1824.
Miller, L. A., Ratnam, K. & Payne, D. J. (2001). Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments. Curr Opin Pharmacol 1, 451–458.[CrossRef][Medline]
Ohta, K., Komatsuzawa, H., Sugai, M. & Suginaka, H. (2000). Triton X-100-induced lipoteichoic acid release is correlated with the methicillin resistance in Staphylococcus aureus. FEMS Microbiol Lett 182, 77–79.[CrossRef][Medline]
Peschel, A., Vuong, C., Otto, M. & Götz, F. (2000). The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother 44, 2845–2847.
Pinho, M. G., de Lencastre, H. & Tomasz, A. (2000). Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus. J Bacteriol 182, 1074–1079.
Raychaudhuri, D. & Chatterjee, A. N. (1985). Use of resistant mutants to study the interaction of Triton X-100 with Staphylococcus aureus. J Bacteriol 164, 1337–1349.
Raynor, R. H., Scott, D. F. & Best, G. K. (1979). Oxacillin-induced lysis of Staphylococcus aureus. Antimicrob Agents Chemother 16, 134–140.
Roos, M., Pittenauer, E., Schmid, E., Beyer, M., Reinike, B., Allmaier, G. & Labischinski, H. (1998). Improved high-performance liquid chromatographic separation of peptidoglycan isolated from various Staphylococcus aureus strains for mass spectrometric characterization. J Chromatogr B Biomed Sci Appl 705, 183–192.[CrossRef][Medline]
Shiota, S., Shimizu, M., Mizushima, T., Ito, H., Hatano, T., Yoshida, T. & Tsuchiya, T. (1999). Marked reduction in the minimum inhibitory concentration (MIC) of beta-lactams in methicillin-resistant Staphylococcus aureus produced by epicatechin gallate, an ingredient of green tea (Camellia sinensis). Biol Pharm Bull 22, 1388–1390.[Medline]
Shirai, C., Sugai, M., Komatsuzawa, H., Ohta, K., Yamakido, M. & Suginaka, H. (1998). A triazine dye, cibacron blue F3GA, decreases oxacillin resistance levels in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 42, 1278–1280.
Sieradzki, K. & Tomasz, A. (1996). A highly vancomycin-resistant laboratory mutant of Staphylococcus aureus. FEMS Microbiol Lett 142, 161–166.[CrossRef][Medline]
Sieradzki, K. & Tomasz, A. (2003). Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 185, 7103–7110.
Sieradzki, K., Pinho, M. G. & Tomasz, A. (1999). Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus. J Biol Chem 274, 18942–18946.
Stapleton, P. D. & Taylor, P. W. (2002). Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog 85, 57–72.[Medline]
Stapleton, P. D., Shah, S., Anderson, J. C., Hara, Y., Hamilton-Miller, J. M. T. & Taylor, P. W. (2004). Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int J Antimicrob Agents 23, 462–467.[CrossRef][Medline]
Stapleton, P. D., Shah, S., Hara, Y. & Taylor, P. W. (2006). Potentiation of catechin gallate-mediated sensitization of Staphylococcus aureus to oxacillin by nongalloylated catechins. Antimicrob Agents Chemother 50, 752–755.
Stranden, A. M., Ehlert, K., Labischinski, H. & Berger-Bächi, B. (1997). Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus. J Bacteriol 179, 9–16.
Sugai, M., Akiyama, T., Komatsuzawa, H., Miyake, Y. & Suginaka, H. (1990). Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis. J Bacteriol 172, 6494–6498.
Sugai, M., Komatsuzawa, H., Akiyama, T., Hong, Y.-M., Oshida, T., Miyake, Y., Yamaguchi, T. & Suginaka, H. (1995). Identification of endo-β-N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus. J Bacteriol 177, 1491–1496.
Suzuki, J., Komatsuzawa, H., Sugai, M., Ohta, K., Kozai, K., Nagasaka, N. & Suginaka, H. (1997). Effects of various types of triton X on the susceptibilities of methicillin-resistant staphylococci to oxacillin. FEMS Microbiol Lett 153, 327–331.[CrossRef][Medline]
Taylor, P. W., Stapleton, P. D. & Paul Luzio, J. (2002). New ways to treat bacterial infections. Drug Discov Today 7, 1086–1091.[CrossRef][Medline]
van Langevelde, P., van Dissel, J. T., Ravensbergen, E., Applemelk, B. J., Schrijver, I. A. & Groeneveld, P. H. P. (1998). Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob Agents Chemother 42, 3073–3078.
Wootton, M., Bennett, P. M., MacGowan, A. P. & Walsh, T. R. (2005). Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains. J Antimicrob Chemother 56, 944–947.
Yam, T. S., Hamilton-Miller, J. M. T. & Shah, S. (1998). The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2' synthesis, and β-lactamase production in Staphylococcus aureus. J Antimicrob Chemother 42, 211–216.
Zhao, W.-H., Hu, Z.-Q., Okubo, S., Hara, Y. & Shimamura, T. (2001). Mechanism of synergy between epigallocatechin gallate and beta-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 45, 1737–1742.
Received 6 March 2007;
revised 30 March 2007;
accepted 5 April 2007.
This article has been cited by other articles:
|
|
 |
|
  M. Doyle, E.-A. Feuerbaum, K. R. Fox, J. Hinds, D. E. Thurston, and P. W. Taylor Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer J. Antimicrob. Chemother., November 1, 2009; 64(5): 949 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bernal, M. Zloh, and P. W. Taylor Disruption of D-alanyl esterification of Staphylococcus aureus cell wall teichoic acid by the {beta}-lactam resistance modifier (-)-epicatechin gallate J. Antimicrob. Chemother., June 1, 2009; 63(6): 1156 - 1162. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
) or presence of 12.5 µg EC ml–1 (
), 12.5 µg ECg ml–1 (
, 
) or 12.5 µg EGCg ml–1 (
, 
). White symbols indicate growth in the absence of exogenous peptidoglycan.
) and MRSA isolates BB568 (
), and EMRSA-16 (
